NAA10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.865400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.015600E-01
Normal-vs-Stage2
6.162400E-01
Normal-vs-Stage3
5.112000E-01
Normal-vs-Stage4
8.966600E-01
Stage1-vs-Stage2
9.311400E-01
Stage1-vs-Stage3
6.232400E-01
Stage1-vs-Stage4
7.221600E-01
Stage2-vs-Stage3
4.616800E-01
Stage2-vs-Stage4
6.296200E-01
Stage3-vs-Stage4
4.762400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.095600E-01
Normal-vs-AfricanAmerican
7.633000E-01
Normal-vs-Asian
2.857000E-01
Caucasian-vs-AfricanAmerican
6.650200E-01
Caucasian-vs-Asian
1.304210E-01
AfricanAmerican-vs-Asian
8.888300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.242600E-01
Normal-vs-Female
5.470000E-01
Male-vs-Female
4.428000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.015400E-01
Normal-vs-Age(41-60Yrs)
5.278600E-01
Normal-vs-Age(61-80Yrs)
6.843600E-01
Normal-vs-Age(81-100Yrs)
5.637600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.938000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.209600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.508400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.853600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.399800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.496000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.837600E-01
Normal-vs-Daily Drinker
3.787800E-01
Normal-vs-Weekly Drinker
3.156200E-01
Normal-vs-Occasional Drinker
4.736000E-01
Normal-vs-Social Drinker
6.205600E-01
Non Drinker-vs-Daily Drinker
6.862000E-01
Non Drinker-vs-Weekly Drinker
1.123210E-01
Non Drinker-vs-Occasional Drinker
6.834000E-01
Non Drinker-vs-Social Drinker
5.080000E-01
Daily Drinker-vs-Weekly Drinker
1.473440E-01
Daily Drinker-vs-Occasional Drinker
9.488000E-01
Daily Drinker-vs-Social Drinker
2.814800E-01
Weekly Drinker-vs-Occasional Drinker
1.669650E-01
Weekly Drinker-vs-Social Drinker
6.888100E-02
Occasional Drinker-vs-Social Drinker
3.286600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.337200E-01
Normal-vs-Grade 2
6.504000E-01
Normal-vs-Grade 3
6.292600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.398200E-01
Grade 1-vs-Grade 3
8.495000E-01
Grade 1-vs-Grade 4
6.337200E-01
Grade 2-vs-Grade 3
2.174600E-01
Grade 2-vs-Grade 4
6.504000E-01
Grade 3-vs-Grade 4
6.292600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.039800E-01
Normal-vs-NonDiabetic
4.432200E-01
Diabetic-vs-NonDiabetic
2.877700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.037430E-01
Normal-vs-NoPancreatitis
5.805000E-01
Pancreatitis-vs-NoPancreatitis
4.641800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.418600E-01
Normal-vs-N1
6.659400E-01
N0-vs-N1
1.975640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.619000E-01
Normal-vs-TP53-NonMutant
9.024200E-01
TP53-Mutant-vs-TP53-NonMutant
3.261500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
